We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+44.38%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$253M
AUM Growth
+$41.5M
Cap. Flow
-$8.84M
Cap. Flow %
-3.5%
Top 10 Hldgs %
58.67%
Holding
56
New
8
Increased
14
Reduced
10
Closed
17

Top Buys

Rank Stock Value
1
PROF
Profound Medical
PROF
+$6.14M
2
SCPH
scPharmaceuticals
SCPH
+$5.15M
3
LPSN icon
LivePerson
LPSN
+$4.94M
4
THTX
Theratechnologies
THTX
+$4.39M
5
INAB icon
IN8bio
INAB
+$4.37M

Top Sells

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$15.8M
2
AVNW icon
Aviat Networks
AVNW
+$9.91M
3
MRAM icon
Everspin Technologies
MRAM
+$8.34M
4
BWEN icon
Broadwind
BWEN
+$3.17M
5
CLNN icon
Clene
CLNN
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 55.66%
2 Technology 27.01%
3 Industrials 17.27%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASPN icon
1
Aspen Aerogels
ASPN
$342M
$28.5M 11.27%
1,804,484
+52,462
+3% +$542K
SCPH
2
DELISTED
scPharmaceuticals
SCPH
$19.5M 7.71%
3,106,795
+899,786
+41% +$5.15M
INDI icon
3
indie Semiconductor
INDI
$638M
$18.3M 7.24%
2,255,000
+155,000
+7% +$1.01M
TGAN
4
DELISTED
Transphorm, Inc. Common Stock
TGAN
$16.9M 6.67%
4,621,058
+1,500
+0% +$4.11K
OUST icon
5
Ouster
OUST
$2.13B
$14.2M 5.64%
1,857,114
+569,121
+44% +$2.98M
MYO icon
6
Myomo
MYO
$36.4M
$13.4M 5.29%
2,668,290
+479,407
+22% +$1.28M
ELVA
7
Electrovaya
ELVA
$375M
$10.3M 4.06%
3,353,308
– –
ALIM
8
DELISTED
Alimera Sciences
ALIM
$9.62M 3.8%
2,226,068
-146,504
-6% -$495K
TELA icon
9
TELA Bio
TELA
$30.9M
$9.12M 3.61%
1,377,945
+125,000
+10% +$722K
BDSX icon
10
Biodesix
BDSX
$215M
$8.57M 3.39%
232,947
-12,388
-5% -$389K
COYA icon
11
Coya Therapeutics
COYA
$92.9M
$7.38M 2.92%
1,031,977
+496,183
+93% +$2.75M
BWAY
12
Brainsway
BWAY
$576M
$6.73M 2.66%
2,077,056
-632,988
-23% -$1.53M
SPRB
13
Spruce Biosciences
SPRB
$113M
$6.22M 2.46%
28,318
+12,171
+75% +$1.41M
LPSN icon
14
LivePerson
LPSN
$22.4M
$6.1M 2.41%
+107,327
New +$4.94M
THTX
15
DELISTED
Theratechnologies
THTX
$6.03M 2.38%
3,719,302
+2,915,906
+363% +$4.39M
APLT
16
DELISTED
Applied Therapeutics
APLT
$5.56M 2.2%
1,659,039
+865,689
+109% +$2.15M
PROF
17
Profound Medical
PROF
$264M
$5.49M 2.17%
+646,733
New +$6.14M
APYX icon
18
Apyx Medical
APYX
$158M
$5.35M 2.12%
2,040,540
+145,309
+8% +$352K
CLRB icon
19
Cellectar Biosciences
CLRB
$20.2M
$5.31M 2.1%
63,841
+41,257
+183% +$3.07M
INAB icon
20
IN8bio
INAB
$10.3M
$5.22M 2.06%
+136,612
New +$4.37M
DCTH icon
21
Delcath Systems
DCTH
$400M
$4.92M 1.95%
+1,182,198
New +$3.87M
LPTH icon
22
Lightpath Technologies
LPTH
$591M
$4.69M 1.86%
3,723,932
– –
RCAT icon
23
Red Cat Holdings
RCAT
$1.05B
$4.42M 1.75%
+5,026,104
New +$4.31M
BKTI icon
24
BK Technologies
BKTI
$293M
$4.05M 1.6%
330,896
– –
ABEO icon
25
Abeona Therapeutics
ABEO
$340M
$3.95M 1.56%
787,769
-347,483
-31% -$1.53M
1
2 3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, AIGH Capital Management held 56 positions worth $253M, up 20% from $211M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

AIGH Capital Management withdrew a net $8.84M in Q4 2023, closing 17 positions and reducing 10 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 51% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Profound Medical worth $5.49M.

  • AIGH Capital Management's largest Q4 2023 buy was Profound Medical: 646,733 shares worth $5.49M.
  • AIGH Capital Management added most to scPharmaceuticals in Q4 2023, an estimated $5.15M increase.
  • AIGH Capital Management's biggest Q4 2023 reduction was GSI Technology, cutting an estimated $2.65M.
  • AIGH Capital Management fully exited ANI Pharmaceuticals in Q4 2023, selling an estimated $15.8M.
  • AIGH Capital Management's ten largest holdings make up 59% of its $253M portfolio in Q4 2023.
  • AIGH Capital Management opened 8 new positions and closed 17 in Q4 2023.
  • AIGH Capital Management's portfolio value rose 20% quarter-over-quarter to $253M.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.